67 related articles for article (PubMed ID: 1825562)
1. A novel method for the analysis of PAF and alkyl-ether phospholipids by mass spectrometry.
Balazy M; Cluzel J; Bazan NG
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():323-6. PubMed ID: 1825562
[No Abstract] [Full Text] [Related]
2. Determination of platelet-activating factor and alkyl-ether phospholipids by gas chromatography-mass spectrometry via direct derivatization.
Balazy M; Braquet P; Bazan NG
Anal Biochem; 1991 Jul; 196(1):1-10. PubMed ID: 1888023
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of platelet activating factor treated with pentafluorobenzoyl chloride using gas chromatography/negative ion chemical ionization mass spectrometry.
Shindo K; Hashimoto Y
Drugs Exp Clin Res; 1991; 17(7):343-9. PubMed ID: 1794300
[TBL] [Abstract][Full Text] [Related]
4. Determination of platelet-activating factor in biological samples by high resolution mass spectrometry.
Magni F; Berti F; De Angelis L; Rossoni G; Galli G
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():327-30. PubMed ID: 1825563
[No Abstract] [Full Text] [Related]
5. Determination of 1-O-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine, platelet-activating factor and related phospholipids in biological samples by high-performance liquid chromatography--tandem mass spectrometry.
Savu SR; Silvestro L; Sörgel F; Montrucchio G; Lupia E; Camussi G
J Chromatogr B Biomed Appl; 1996 Jun; 682(1):35-45. PubMed ID: 8832423
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel steroid-modified ether phospholipids.
Karantonis HC; Pitsinos EN; Antonopoulou S; Couladouros EA; Demopoulos CA
Chem Phys Lipids; 2005 Dec; 138(1-2):12-9. PubMed ID: 16202400
[TBL] [Abstract][Full Text] [Related]
7. Analysis of platelet activating factor in human saliva by gas chromatography/mass spectrometry.
Christman BW; Blair IA
Biomed Environ Mass Spectrom; 1989 Apr; 18(4):258-64. PubMed ID: 2706378
[TBL] [Abstract][Full Text] [Related]
8. Distribution of alkyl and alkenyl ether-linked phospholipids and platelet-activating factor-like lipid in various species of invertebrates.
Sugiura T; Fukuda T; Miyamoto T; Waku K
Biochim Biophys Acta; 1992 Jun; 1126(3):298-308. PubMed ID: 1637858
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of platelet activating factor and related ether lipids: enzymatic pathways, subcellular sites, regulation, and membrane processing.
Snyder F
Prog Clin Biol Res; 1988; 282():57-72. PubMed ID: 3071807
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of platelet activating factor using fast atom bombardment/tandem mass spectrometry.
Haroldsen PE; Gaskell SJ
Biomed Environ Mass Spectrom; 1989 Jun; 18(6):439-44. PubMed ID: 2504312
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor.
Owen JS; Thomas MJ; Wykle RL
Methods Enzymol; 2007; 434():105-16. PubMed ID: 17954244
[TBL] [Abstract][Full Text] [Related]
12. Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A23187.
Oda M; Satouchi K; Yasunaga K; Saito K
J Immunol; 1985 Feb; 134(2):1090-3. PubMed ID: 3917470
[TBL] [Abstract][Full Text] [Related]
13. Analysis of lyso-platelet activating factor by negative ion gas chromatography/mass spectrometry of the nitrobenzal acetal derivatives.
Mallet AI
Biomed Environ Mass Spectrom; 1988 Oct; 16(1-12):207-10. PubMed ID: 3242671
[TBL] [Abstract][Full Text] [Related]
14. Species-specific variations in the molecular heterogeneity of the platelet-activating factor.
Ramesha CS; Pickett WC
J Immunol; 1987 Mar; 138(5):1559-63. PubMed ID: 3100641
[TBL] [Abstract][Full Text] [Related]
15. Molecular heterogeneity of PAF in normal human mixed saliva: quantitative mass spectral analysis after direct derivatization of PAF with pentafluorobenzoic anhydride.
Woodard DS; Mealey BL; Lear CS; Satsangi RK; Prihoda TJ; Weintraub ST; Pinckard RN; McManus LM
Biochim Biophys Acta; 1995 Nov; 1259(2):137-47. PubMed ID: 7488633
[TBL] [Abstract][Full Text] [Related]
16. Quantification of distinct molecular species of the 2-lyso metabolite of platelet-activating factor by gas chromatography-negative-ion chemical ionization mass spectrometry.
Turk J; Bohrer A; Stump WT; Ramanadham S; Mangino MJ
J Chromatogr; 1992 Mar; 575(2):183-96. PubMed ID: 1629294
[TBL] [Abstract][Full Text] [Related]
17. Determination of MK-287, a new platelet-activating factor antagonist, in plasma and serum by gas chromatography chemical ionization mass spectrometry.
Fisher AL; Morris MJ; Gilbert JD
Biol Mass Spectrom; 1991 Jul; 20(7):408-14. PubMed ID: 1932155
[TBL] [Abstract][Full Text] [Related]
18. Biochemical evidence of platelet-activating factor (PAF) in human middle ear effusions.
Furukawa M; Kubo N; Yamashita T
Laryngoscope; 1995 Feb; 105(2):188-91. PubMed ID: 8544602
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor and its structural analogues in the earthworm Eisenia foetida.
Sugiura T; Yamashita A; Kudo N; Fukuda T; Miyamoto T; Cheng NN; Kishimoto S; Waku K; Tanaka T; Tsukatani H
Biochim Biophys Acta; 1995 Aug; 1258(1):19-26. PubMed ID: 7654776
[TBL] [Abstract][Full Text] [Related]
20. [Synthesis of phosphono analogs of a phospholipid platelet activating factor].
Chuvilin AN; Trusov VG; Serebrennikova GA
Bioorg Khim; 1992 Jun; 18(6):862-70. PubMed ID: 1418000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
